Occult hepatic opportunistic infection (OI) and highly active antiretroviral therapy (HAART) induced immune reconstitution: An important cause of jaundice in a patient with AIDS

AIDS Research and Human Retroviruses

Volumn 22, Issue 10, 2006, Pages 1052-1053

  Verma, Sumita ^a,b   Bhakta, Hetal ^b   Nowain, Arash ^b   Kanel, Gary ^b   Squires, Kathleen ^b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CD4 ANTIGEN; CD8 ANTIGEN; ISONIAZID; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; TENOFOVIR; TUBERCULOSTATIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CASE REPORT; CD4 LYMPHOCYTE COUNT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; JAUNDICE; LETTER; LIVER TOXICITY; MALE; MYCOBACTERIUM TUBERCULOSIS; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; SIDE EFFECT; TUBERCULOUS LYMPHADENITIS; TUBERCULOUS MENINGITIS; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTITUBERCULAR AGENTS; HUMANS; JAUNDICE; MALE; TUBERCULOSIS, MENINGEAL;

EID: 33846225654     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.22.1052     Document Type: Letter

References (5)

1. Nunez M, Lana R, Mendoza JL, Martin-Carbonero L, and Soriano V: Risk factors for severe hepatic injury after introduction of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2001;27:426-431.
2. Sulkowski MS, Thomas DL, Mehta SH, Chaisson RE, and Moore RD: Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: Role of hepatitis C and B infections. Hepatology 2002;35:182-189.
3. French MA, Price P, and Stone SF: Immune restoration disease after antiretroviral therapy. AIDS 2004;18(12):1615-1627.
4. French MA, Lenzo N, John M, et al.: Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy. HIV Med 2000;1(2):107-115.
5. The antiretroviral therapy cohort collaboration: Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America. Clin Infect Dis 2005;41:1772-1782.